All Resources
App Note
Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates with Opto™ Plasma B Discovery

Discover how to maximize hit recovery and rapidly down-select blocking antibodies from plasma B cells in a single day.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this App Note we discuss:

Maximize hit recovery and down-select blocking antibodies from plasma B cells in a single day.
Access greater diversity by screening B cells from multiple organs, such as bone marrow and spleen.
Rapidly down-select lead candidates with confirmed binding and blocking activity in plate-based assays.
A Deeper Look

More about this App Note

Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates

In this application note, we demonstrate how Opto Plasma B Discovery enables the rapid selection of receptor-ligand blocking antibodies using the therapeutically-relevant PD-1/PD-L1 model system. Download to learn more and review the case studies.

Get the App Note